Robot-assisted versus open partial nephrectomy: comparison of outcomes. A systematic review.


Journal

Minerva urologica e nefrologica = The Italian journal of urology and nephrology
ISSN: 1827-1758
Titre abrégé: Minerva Urol Nefrol
Pays: Italy
ID NLM: 8503649

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 22 3 2019
medline: 21 8 2019
entrez: 22 3 2019
Statut: ppublish

Résumé

Robot-assisted partial nephrectomy (RAPN) is increasingly used for the surgical management of renal masses. Aim of this study was to analyze the available literature regarding the outcomes of RAPN compared to those of open partial nephrectomy (OPN). A literature search was performed up to October 2018 using PubMed, MEDLINE and Embase. Article selection followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) principles and Population, Intervention, Comparator, Outcomes (PICO) methodology was used. Population (P) was patients with renal masses who underwent RAPN (I). RAPN was compared with OPN (C). Outcomes of interest were perioperative, oncological and functional outcomes of both surgical procedures (O). Inclusion criteria were: randomized controlled studies andobservational cohort studies comparing RAPN versus OPN, which reported at least one outcome of interest. Twenty-two manuscripts met our inclusion criteria and were included in the systematic review. RAPN was superior to OPN in terms of complication rate in 11 studies while similar results were observed in 9 studies. Positive surgical margins were similar in 13 studies while RAPN had lower surgical margins in 6 studies. Operative and warm ischemia times were longer in OPN in 13 and 10 studies, respectively. Seventeen and 19 studies showed that estimated blood loss and length of hospital stay were higher in RAPN. Estimated glomerular filtration rate decline and chronic kidney disease upstaging decline were similar in the majority of studies. Current evidence demonstrate that RAPN is a reasonable alternative to OPN with regard to oncological and early functional outcomes with a straightforward advantage of improved perioperative morbidity, as expected by minimally invasive techniques. Nevertheless, there is still a great need for well-designed randomized studies with an extended follow-up.

Identifiants

pubmed: 30895768
pii: S0393-2249.19.03391-5
doi: 10.23736/S0393-2249.19.03391-5
doi:

Types de publication

Comparative Study Journal Article Systematic Review

Langues

eng

Pagination

113-120

Investigateurs

Wouter Everaerts (W)
Sanchia Goonewardene (S)
Giovannalberto Pini (G)
Achilles Ploumidis (A)
Josep G Sopena (JG)
Anna Wallerstedt Lantz (A)

Auteurs

Nikolaos Grivas (N)

Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands - nikolaosgrivas@hotmail.com.
Department of Urology, G. Hatzikosta General Hospital, Ioannina, Greece - nikolaosgrivas@hotmail.com.

Nikolaos Kalampokis (N)

Department of Urology, G. Hatzikosta General Hospital, Ioannina, Greece.

Alessandro Larcher (A)

Department of Urology, OLV, Aalst, Belgium.
ORSI Academy, Melle, Belgium.
Division of Oncology, Unit of Urology, URI, San Raffaele IRCCS Hospital, Milan, Italy.

Stavros Tyritzis (S)

Section of Urology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Center for Minimally Invasive Urological Surgery, Athens Medical Center, Athens, Greece.

Koon H Rha (KH)

Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.

Vincenzo Ficarra (V)

Section of Urology, Gaetano Barresi Department of Human and Pediatric Pathology, University of Messina, Messina, Italy.

Nicoló Buffi (N)

Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.

Achilles Ploumidis (A)

Department of Urology, Athens Medical Center, Athens, Greece.

Riccardo Autorino (R)

Division of Urology, McGuire VAMC and VCU Health Center, Richmond, VA, USA.

Francesco Porpiglia (F)

Department of Urology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Henk van der Poel (H)

Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Alexandre Mottrie (A)

Department of Urology, OLV, Aalst, Belgium.
ORSI Academy, Melle, Belgium.

Geert de Naeyer (G)

Department of Urology, OLV, Aalst, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH